Cromwell Holdings’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5K Buy
11
+5
+83% +$614 ﹤0.01% 909
2026
Q1
$707 Hold
6
﹤0.01% 929
2025
Q4
$983 Hold
6
﹤0.01% 831
2025
Q3
$803 Hold
6
﹤0.01% 878
2025
Q2
$746 Buy
6
+5
+500% +$636 ﹤0.01% 873
2025
Q1
$127 Buy
+1
New +$154 ﹤0.01% 817

Other funds holding RGEN

Cromwell Holdings's RGEN Position: Q2 2026 in Review

Cromwell Holdings increased its Repligen (RGEN) stake by 83% in Q2 2026, buying an estimated $614 and bringing the position to 11 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Cromwell Holdings first reported a position in RGEN in Q1 2025 and has held it in 6 quarters since. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Cromwell Holdings held 11 shares of Repligen worth $1.5K as of Q2 2026.
  • Cromwell Holdings bought 5 Repligen shares in Q2 2026, an estimated $614.
  • Repligen made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #909 holding.
  • Cromwell Holdings first reported a position in Repligen in Q1 2025 and has held it in 6 quarters since.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.